Bellerophon Therapeutics, Inc.
BLPHDelisted Dec 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001600132
Bellerophon Therapeutics, Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Oct 16, 2023; 22 institutions reported holding it in 13F filings for Q3 2023, worth $506.6K in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Bellerophon Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- +6 vs. Q3 2022
- Shares held
- 925.5K
- −158.4K (−14.6%) vs. Q3 2022
- Total value
- $832.7K
- −$349.3K (−29.5%) vs. Q3 2022
- New holders
- 7
- 1 more added
- Sold out
- 1
- 8 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BLPH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 2 | $6.37K |
| Q3 2023 | 22 | $506.6K |
| Q2 2023 | 23 | $824.9K |
| Q1 2023 | 19 | $27.9M |
| Q4 2022 | 25 | $832.7K |
| Q3 2022 | 19 | $1.18M |
| Q2 2022 | 19 | $1.40M |
| Q1 2022 | 22 | $2.68M |
| Q4 2021 | 22 | $3.82M |
| Q3 2021 | 22 | $4.81M |
| Q2 2021 | 27 | $6.34M |
| Q1 2021 | 39 | $10.9M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Bellerophon Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 191,065 | $172.0K | 0.00% | −8,998−4.5% | Reduced |
| Renaissance Technologies LLC | 171,799 | $155.0K | 0.00% | −24,392−12.4% | Reduced |
| Vanguard Group Inc | 145,810 | $131.2K | 0.00% | −199,384−57.8% | Reduced |
| BlackRock Inc. | 100,625 | $90.6K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 64,196 | $57.0K | 0.00% | −159−0.2% | Reduced |
| Telemetry Investments, L.L.C. | 44,000 | $40.0K | 0.09% | −3,500−7.4% | Reduced |
| Northern Trust Corp | 28,097 | $25.3K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 28,035 | $25.0K | 0.00% | +28,035 | New |
| Sepio Capital, LP | 23,800 | $21.4K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 22,944 | $21.0K | 0.00% | +22,944 | New |
| State Street Corp | 21,327 | $19.2K | 0.00% | 00.0% | Unchanged |
| Tudor Investment Corp Et Al | 20,000 | $18.0K | 0.00% | 00.0% | Unchanged |
| Ergoteles LLC | 14,891 | $13.4K | 0.00% | +14,891 | New |
| Jane Street Group, LLC | 13,762 | $12.4K | 0.00% | +13,762 | New |
| NTV Asset Management LLC | 12,605 | $11.3K | 0.00% | +12,605 | New |
| Destination Wealth Management | 10,000 | $9.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 5,872 | $5.00K | 0.00% | −1,689−22.3% | Reduced |
| UBS Group AG | 2,297 | $2.07K | 0.00% | +2,297 | New |
| Morgan Stanley | 1,477 | $1.33K | 0.00% | +7+0.5% | Added |
| US Bancorp | 1,221 | $1.10K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 500 | $450 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 100 | $0 | 0.00% | −8−7.4% | Reduced |
| Royal Bank of Canada | 79 | $0 | 0.00% | −174−68.8% | Reduced |
| Sofos Investments, Inc. | 1 | – | – | +1 | New |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −14,663−100.0% | Sold out |